₃P Mulsant

Key Opinion Leader In [P Mulsant is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (32) [keywords assigned to P Mulsant articles by PubMed, the leading number and the color conveys importance]

₃Female | ₂Sheep | ₂Humans | ₂Animals | ₂Receptors, Growth Factor | ₂Protein-Serine-Threonine Kinases | ₂Male | ₂Bone Morphogenetic Protein Receptors, Type I | ₂Genotype | ₁Granulosa Cells | ₁Antineoplastic Agents | ₁Transforming Growth Factor beta | ₁Signal Transduction | ₁Pleural Neoplasms | ₁Point Mutation | ₁Adult | ₁Survival Analysis | ₁Hyperthermia, Induced | ₁Reproduction | ₁Bone Morphogenetic Proteins | ₁Progesterone | ₁Mitomycin | ₁Inhibin-beta Subunits | ₁Ovulation | ₁Middle Aged | ₁France | ₁Cells, Cultured | ₁Activins | ₁Transfection | ₁Combined Modality Therapy | ₁Cell Line | ₁Aged

Other [context-specific ads]

P Mulsant Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Mulsant might be a good expert witness on these terms]

₇genes | ₆mutation | ₆sheep | ₅patients | ₄booroola | ₄associated | ₃itch | ₃morphogenetic | ₃protein | ₃bone | ₃survival | ₃programmes | ₃genetic | ₃long-term | ₃alteration | ₃french | ₃months | ₃gene | ₂bmpr1b | ₂intrathoracic | ₂pleural | ₂bmp-4 | ₂chemohyperthermia | ₂identify | ₂q249r | ₂functionality | ₂treatment | ₂receptor-ib | ₂fibrosarcoma | ₂malignancies | ₂lacaune | ₂results
₃bone morphogenetic | ₃morphogenetic protein | ₃genetic programmes | ₃french genetic | ₃genes sheep | ₃prolificacy genes | ₂pleural malignancies | ₂sheep associated | ₂long-term results | ₂associated alteration | ₂protein receptor-ib | ₂mutation sheep | ₂itch treatment | ₂results intrathoracic | ₂booroola mutation | ₂alteration bone | ₂receptor-ib functionality | ₂chemohyperthermia itch | ₂treatment pleural | ₂intrathoracic chemohyperthermia | ₂fibrosarcoma patients | ₂t2 mesothelioma | ₂sheep french | ₂t1 t2 | ₂mesothelioma patients | ₁follicles overall | ₁mutation q249r | ₁induction activity | ₁form bmpr1b | ₁months lacaune | ₁receptor type | ₁valuable resource
₃bone morphogenetic protein | ₃french genetic programmes | ₃prolificacy genes sheep | ₂morphogenetic protein receptor-ib | ₂sheep associated alteration | ₂protein receptor-ib functionality | ₂associated alteration bone | ₂itch treatment pleural | ₂mutation sheep associated | ₂long-term results intrathoracic | ₂treatment pleural malignancies | ₂booroola mutation sheep | ₂chemohyperthermia itch treatment | ₂intrathoracic chemohyperthermia itch | ₂results intrathoracic chemohyperthermia | ₂alteration bone morphogenetic | ₂genes sheep french | ₂t1 t2 mesothelioma | ₂t2 mesothelioma patients | ₂sheep french genetic | ₁programmes demonstrated variations | ₁limited linkage testing | ₁survival rates respectively | ₁procedure | ₁transfected fecb form | ₁receptor t1 t2 | ₁lacaune gene situated | ₁months t3 t4 | ₁fecb form bmpr1b | ₁genetic programmes long-term | ₁associated segregation several | ₁development ovarian follicles

Authoratory™
•home •community •tutorial •authors •keywords •search •top ranked •login	Update 2008, Q3 Live! Excel CSV XML print ₃P Mulsant << 2002 \| 2003 \| 2008 Summary Social Network Interests Funding Articles Comments All Key Opinion Leader In [P Mulsant is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors] no keywords assigned Keywords (32) [keywords assigned to P Mulsant articles by PubMed, the leading number and the color conveys importance] ₃Female \| ₂Sheep \| ₂Humans \| ₂Animals \| ₂Receptors, Growth Factor \| ₂Protein-Serine-Threonine Kinases \| ₂Male \| ₂Bone Morphogenetic Protein Receptors, Type I \| ₂Genotype \| ₁Granulosa Cells \| ₁Antineoplastic Agents \| ₁Transforming Growth Factor beta \| ₁Signal Transduction \| ₁Pleural Neoplasms \| ₁Point Mutation \| ₁Adult \| ₁Survival Analysis \| ₁Hyperthermia, Induced \| ₁Reproduction \| ₁Bone Morphogenetic Proteins \| ₁Progesterone \| ₁Mitomycin \| ₁Inhibin-beta Subunits \| ₁Ovulation \| ₁Middle Aged \| ₁France \| ₁Cells, Cultured \| ₁Activins \| ₁Transfection \| ₁Combined Modality Therapy \| ₁Cell Line \| ₁Aged Other [context-specific ads] P Mulsant Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Mulsant might be a good expert witness on these terms] ₇genes \| ₆mutation \| ₆sheep \| ₅patients \| ₄booroola \| ₄associated \| ₃itch \| ₃morphogenetic \| ₃protein \| ₃bone \| ₃survival \| ₃programmes \| ₃genetic \| ₃long-term \| ₃alteration \| ₃french \| ₃months \| ₃gene \| ₂bmpr1b \| ₂intrathoracic \| ₂pleural \| ₂bmp-4 \| ₂chemohyperthermia \| ₂identify \| ₂q249r \| ₂functionality \| ₂treatment \| ₂receptor-ib \| ₂fibrosarcoma \| ₂malignancies \| ₂lacaune \| ₂results ₃bone morphogenetic \| ₃morphogenetic protein \| ₃genetic programmes \| ₃french genetic \| ₃genes sheep \| ₃prolificacy genes \| ₂pleural malignancies \| ₂sheep associated \| ₂long-term results \| ₂associated alteration \| ₂protein receptor-ib \| ₂mutation sheep \| ₂itch treatment \| ₂results intrathoracic \| ₂booroola mutation \| ₂alteration bone \| ₂receptor-ib functionality \| ₂chemohyperthermia itch \| ₂treatment pleural \| ₂intrathoracic chemohyperthermia \| ₂fibrosarcoma patients \| ₂t2 mesothelioma \| ₂sheep french \| ₂t1 t2 \| ₂mesothelioma patients \| ₁follicles overall \| ₁mutation q249r \| ₁induction activity \| ₁form bmpr1b \| ₁months lacaune \| ₁receptor type \| ₁valuable resource ₃bone morphogenetic protein \| ₃french genetic programmes \| ₃prolificacy genes sheep \| ₂morphogenetic protein receptor-ib \| ₂sheep associated alteration \| ₂protein receptor-ib functionality \| ₂associated alteration bone \| ₂itch treatment pleural \| ₂mutation sheep associated \| ₂long-term results intrathoracic \| ₂treatment pleural malignancies \| ₂booroola mutation sheep \| ₂chemohyperthermia itch treatment \| ₂intrathoracic chemohyperthermia itch \| ₂results intrathoracic chemohyperthermia \| ₂alteration bone morphogenetic \| ₂genes sheep french \| ₂t1 t2 mesothelioma \| ₂t2 mesothelioma patients \| ₂sheep french genetic \| ₁programmes demonstrated variations \| ₁limited linkage testing \| ₁survival rates respectively \| ₁procedure \| ₁transfected fecb form \| ₁receptor t1 t2 \| ₁lacaune gene situated \| ₁months t3 t4 \| ₁fecb form bmpr1b \| ₁genetic programmes long-term \| ₁associated segregation several \| ₁development ovarian follicles

	The content of this page was generated automatically by a computer program. Copyright © 2006-2009 Authoratory.com \| All rights reserved \| Terms of use \| Privacy policy

3P Mulsant

Key Opinion Leader In [P Mulsant is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

Keywords (32) [keywords assigned to P Mulsant articles by PubMed, the leading number and the color conveys importance]

Other [context-specific ads]

P Mulsant Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Mulsant might be a good expert witness on these terms]

₃P Mulsant